Dewpoint Therapeutics Partners with Chemify to apply ground-breaking Chemistry AI to radically accelerate the discovery of molecules
Eos portfolio company ENOUGH raises 40m euro scale-up equity investment
Glasgow firm Chemify raises £33m to ‘digitise’ chemistry
Carcinotech – How Bioprinting Can Improve Cancer Treatments
CNBC report about how ENOUGH, the Strathclyde spin-out and Eos portfolio company, thinks its fungi-based protein may be the solution to the unsustainable impact of sole reliance on traditional protein farming
British Business Investments commits £10m via its Regional Angels Programme
A warm welcome to Jill Arnold CA to the Eos team. As we continue to support impactful science and technology across Scotland and beyond, we really value the experience and vision that Jill brings to our work
Welcoming Bioliberty to the Eos portfolio
Stewart demands government action on female entrepreneurship
Significant growth round for Dxcover’s early stage cancer test
